ES2193414T3 - Dihidrobenzofuranos sustituidos como inhibidores de la pde. - Google Patents

Dihidrobenzofuranos sustituidos como inhibidores de la pde.

Info

Publication number
ES2193414T3
ES2193414T3 ES97950157T ES97950157T ES2193414T3 ES 2193414 T3 ES2193414 T3 ES 2193414T3 ES 97950157 T ES97950157 T ES 97950157T ES 97950157 T ES97950157 T ES 97950157T ES 2193414 T3 ES2193414 T3 ES 2193414T3
Authority
ES
Spain
Prior art keywords
pde
inhibitors
dihydrobenzofurans
substituted
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97950157T
Other languages
English (en)
Inventor
Hermann Amschler
Thomas Bar
Dieter Flockerzi
Beate Schmidt
Ulrich Thibaut
Armin Hatzelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of ES2193414T3 publication Critical patent/ES2193414T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), EN LA QUE R1 ES ALCOXI C 1-6 , CICLOALCOXI C 3-7 , CICLOALQUILMETOXI C 3-7 , BENCILOXI O ALCOXI C 1-4 PARCIAL O TOTALMENTE SUSTITUIDO POR FLUOR; R2 ES ALQUILO C 1-4 ; Y R3 ES HIDROGENO O ALQUILO C 1-4 ; O R2 Y R3, CONJUNTAMENTE E INCLUYENDO LOS DOS ATOMOS DE CARBONO A LOS QUE ESTAN UNIDOS, SON UN ANILLO HIDROCARBONADO DE 5, 6 O 7 MIEMBROS, DE ESTRUCTURA ESPIRO, SI SE DESEA INTERRUMPIDO POR UN ATOMO DE OXIGENO O POR UN GRUPO IMINO (- NH -); R4 ES HIDROGENO, HIDROXILO, NITRO, CIANO, CARBOXILO, ALCOXI C 1-4 O ALCOXICARBONILO C 1-4 ; A ES B, - CH(R5) - O > C = N - R6, DONDE B ES OXIGENO (- O -), IMINO (- NH -), SULFINILO (- S(O) ), SULFONILO (- S(O) SUB,2 -) O CARBONILIMINO (- C(O)NH -); Y R5 ES CARBOXILO, ALCOXICARBONILO C 1-4 , AMINOCARBONILO, MONO O DIALQUILAMINOCARB ONILO C 1-4 , HIDROXILAMINOCARBONILO (- C(O)NHOH), ALCOXIAMINOCARBONILO C 1-4 O UN RADICAL DE FORMULA (A), DONDE R51 ES HIDROGENO, ALQUILO C 1-4 O ARILO Y R52 ES HIDROGENO, ALQUILO C 1-4 O ARILO, DONDE ARILO ES UN RADICAL FENILO, PIRIDILO, BENCILO O FENETILO, QUE PUEDE NO ESTAR SUSTITUIDO O ESTAR MONO O DISUSTITUIDO POR HIDROXILO, ALCOXI C 1-4 , HALOGENO, AMINO, CIANO O NITRO; R6 ES HIDROXILO O ALQUILCARBONILOXI C 1-4 . DICHOS COMPUESTOS Y SUS SALES SON INHIBIDORES EFECTIVOS DE LA FOSFODIESTERASA (PDE).
ES97950157T 1996-11-20 1997-11-11 Dihidrobenzofuranos sustituidos como inhibidores de la pde. Expired - Lifetime ES2193414T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19647881 1996-11-20
EP96118743 1996-11-22

Publications (1)

Publication Number Publication Date
ES2193414T3 true ES2193414T3 (es) 2003-11-01

Family

ID=26031440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97950157T Expired - Lifetime ES2193414T3 (es) 1996-11-20 1997-11-11 Dihidrobenzofuranos sustituidos como inhibidores de la pde.

Country Status (12)

Country Link
US (1) US6054475A (es)
EP (1) EP0941221B1 (es)
JP (1) JP2001505198A (es)
AT (1) ATE233252T1 (es)
AU (1) AU5320698A (es)
CY (1) CY2472B1 (es)
DE (1) DE69719358T2 (es)
DK (1) DK0941221T3 (es)
ES (1) ES2193414T3 (es)
PT (1) PT941221E (es)
SI (1) SI0941221T1 (es)
WO (1) WO1998022453A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003525845A (ja) * 1997-10-28 2003-09-02 ヴィヴァス・インコーポレイテッド 勃起機能不全の処置のためのホスホジエステラーゼインヒビターの局所投与
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
CN1440281A (zh) * 2000-05-03 2003-09-03 苏坎波公司 降眼压药
JP3940290B2 (ja) * 2000-12-22 2007-07-04 ザ・ヨルダニアン・フアーマシユーテイカル・エム・エフ・ジー・アンド・メデイカル・イクイツプメント・カンパニー・リミテツド 新規化合物
SE0004780D0 (sv) * 2000-12-22 2000-12-22 Jordanian Pharmaceutical Mfg & Novel compunds
EP1256578B1 (en) * 2001-05-11 2006-01-11 Pfizer Products Inc. Thiazole derivatives and their use as cdk inhibitors
DE60235198D1 (de) * 2001-12-20 2010-03-11 Merck Serono Sa Coinsins Pyrrolidin-derivatie als prostaglandin-modulatoren
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US7153824B2 (en) 2003-04-01 2006-12-26 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
DE10348022A1 (de) * 2003-10-15 2005-05-25 Imtm Gmbh Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552438A (en) * 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
DK0772610T3 (da) * 1994-07-22 2001-01-29 Byk Gulden Lomberg Chem Fab Dihydrobenzofuraner
ATE231501T1 (de) * 1995-05-18 2003-02-15 Altana Pharma Ag Phenyldihydrobenzofurane
DK0828727T3 (da) * 1995-05-18 2003-04-22 Altana Pharma Ag Cyclohexyldihydrobenzofuraner

Also Published As

Publication number Publication date
PT941221E (pt) 2003-07-31
DK0941221T3 (da) 2003-06-10
SI0941221T1 (en) 2003-10-31
WO1998022453A1 (en) 1998-05-28
DE69719358D1 (de) 2003-04-03
ATE233252T1 (de) 2003-03-15
JP2001505198A (ja) 2001-04-17
EP0941221B1 (en) 2003-02-26
US6054475A (en) 2000-04-25
AU5320698A (en) 1998-06-10
DE69719358T2 (de) 2003-12-24
CY2472B1 (en) 2005-06-03
EP0941221A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
ES2193414T3 (es) Dihidrobenzofuranos sustituidos como inhibidores de la pde.
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
DE69831937D1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
ATE234300T1 (de) Benzonaphthyridine als bronchialtherapeutika
MX9700557A (es) Dihidrobenzofuranos.
BG101422A (bg) Бензоксазолни производни като бронхоразширяващи средства
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
ES2188983T3 (es) Nuevas benzofuran-4-carboxamidas.
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
BR9809185A (pt) Diidropiranos fundidos
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
TR200001452T2 (tr) Bifenilamidin türevleri.
ATE219481T1 (de) 1,7,7-trimethyl-bicyclo(2.2.1)heptane derivative
PT1003724E (pt) Derivados substituidos com accao antiviral
DE60036558D1 (de) Phthalazinon-derivate als pde 4 hemmer
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
PT914129E (pt) Utilizacao de aspirocloro ou derivados seus como agentes imunossupresivos